Anoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
287
|
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2008 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Infarction
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
15
|
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Choroidal Neovascularization
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases
|
Pathologic Function
|
31
|
3
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
95
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Carcinoma, Lewis Lung
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
188
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.973 |
111 |
2
|
2007 |
2020 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.400 |
None |
0.930 |
57 |
5
|
2001 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.957 |
46 |
|
2006 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.955 |
44 |
|
2006 |
2019 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.700 |
None |
0.974 |
38 |
20
|
2001 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.964 |
28 |
1
|
2011 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.964 |
28 |
|
2004 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.100 |
None |
0.963 |
27 |
2
|
2004 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.957 |
23 |
|
2010 |
2019 |
Paraganglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
165
|
36
|
0.400 |
strong |
1.000 |
20 |
|
2006 |
2019 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.100 |
None |
0.938 |
16 |
|
2005 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.100 |
None |
1.000 |
16 |
|
2011 |
2019 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.100 |
None |
0.933 |
15 |
|
2007 |
2019 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.100 |
None |
0.933 |
15 |
|
2007 |
2019 |
Adrenal Gland Pheochromocytoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
416
|
50
|
0.100 |
None |
1.000 |
14 |
|
2001 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.100 |
None |
1.000 |
13 |
1
|
2011 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.100 |
None |
1.000 |
12 |
1
|
2012 |
2019 |
Pheochromocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
344
|
186
|
0.100 |
None |
1.000 |
12 |
|
2001 |
2019 |